Antidepressants that block the reuptake of noradrenaline and/or serotonin are among the first-line treatments for neuropathic pain, although the mechanisms underlying this analgesia remain unclear. The noradrenergic locus coeruleus is an essential element of both the ascending and descending pain modulator systems regulated by these antidepressants. Hence, we investigated the effect of analgesic antidepressants on locus coeruleus activity in Sprague-Dawley rats subjected to chronic constriction injury (CCI), a model of neuropathic pain. In vivo extracellular recordings of locus coeruleus revealed that CCI did not modify the basal tonic activity of this nucleus, although its sensory-evoked response to noxious stimuli was significantly altered. Under normal conditions, noxious stimulation evokes an early response, corresponding to the activation of myelinated A fibers, which is followed by an inhibitory period and a subsequent late capsaicin-sensitive response, consistent with the activation of unmyelinated C fibers. CCI provokes an enhanced excitatory early response in the animals and the loss of the late response. Antidepressant administration over 7 days (desipramine, 10 mg/kg/day or duloxetine, 5 mg/kg/day, delivered by osmotic minipumps) decreased the excitatory firing rate of the early response in the CCI group. Moreover, in all animals, these antidepressants reduced the inhibitory period and augmented the late response. We propose that N-methyl-D-aspartate and alpha-2-adrenoceptors are involved in the analgesic effect of antidepressants. Antidepressant-mediated changes were correlated with behavioral effects indicative of analgesia in healthy and neuropathic rats. Ó
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Introduction
In addition to their effects on mood, antidepressants possess intrinsic analgesic properties, and for this reason, they have been used as analgesics for over 40 years. Indeed, although they form part of the first line of treatment for neuropathic pain, and despite their extensive clinical use for this purpose, the mechanisms underlying the analgesic action of antidepressants remain unclear. The classic hypothesis postulates that antidepressants block specific monoamine (noradrenaline or serotonin) transporters in the presynaptic membrane, maintaining or enhancing the activity of the descending inhibitory bulbospinal pain pathway that is frequently compromised in conditions of neuropathic pain [11, 32, 35] .
However, direct evidence of the involvement of supraspinal areas in neuropathic pain and antidepressant-mediated analgesia, such as the noradrenergic locus coeruleus (LC), has not been forthcoming.
The role of the LC in acute pain has been studied extensively in healthy animals [13, 26, 27] . Inhibition of somatosensory information at the level of the spinal cord by the LC is triggered by nociceptive inputs to the latter, forming a ''brainstem loop.'' LC neurons are activated by sensory stimuli and remarkably, by noxious stimuli such as foot or tail pinch, or sciatic nerve activation [4,13]. For both noxious and nonnoxious stimuli, brief bursting activity (early response) induced by the stimulus is followed by an inhibitory period (Fig. 3) . Additionally, noxious stimuli that recruit C fibers also provoke a specific late response of LC neurons [26] . Thus, the LC electrical response to acute pain is the combined result of the late and early evoked responses. Both acute and chronic administration of antidepressants profoundly influences the electrical activity of LC neurons, and these alterations are thought to mediate their
